(Q48085574)

8 February 2018

title

Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study (English)

1 reference

8 February 2018

1 reference

1 reference

F Bernard

1

1 reference

8 February 2018

P Auquier

2

1 reference

8 February 2018

I Herrmann

3

1 reference

8 February 2018

A Contet

4

1 reference

8 February 2018

M Poiree

5

1 reference

8 February 2018

F Demeocq

6

1 reference

8 February 2018

D Plantaz

7

1 reference

8 February 2018

C Galambrun

8

1 reference

8 February 2018

V Barlogis

9

1 reference

8 February 2018

J Berbis

10

1 reference

8 February 2018

F Garnier

11

1 reference

8 February 2018

N Sirvent

12

1 reference

8 February 2018

J Kanold

13

1 reference

8 February 2018

P Chastagner

14

1 reference

8 February 2018

H Chambost

15

1 reference

8 February 2018

G Michel

16

1 reference

8 February 2018

language of work or name

English

0 references

publication date

17 February 2014

1 reference

8 February 2018

Bone Marrow Transplantation

published in

1 reference

8 February 2018

volume

49

1 reference

8 February 2018

issue

5

1 reference

8 February 2018

page(s)

709-716

1 reference

8 February 2018

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Endocrinological late complications after hematopoietic SCT in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Non-endocrine late complications in children after allogeneic haematopoietic SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Weight-based strategy of dose administration in children using intravenous busulfan: clinical and pharmacokinetic results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

The use of the SF-36 questionnaire in adult survivors of childhood cancer: evaluation of data quality, score reliability, and scaling assumptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Pathobiology of chemotherapy-induced hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Permanent alopecia after busulfan chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Permanent alopecia after cranial irradiation: dose-response relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Height growth during adolescence and final height after haematopoietic SCT for childhood acute leukaemia: the impact of a conditioning regimen with BU or TBI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Longitudinal changes in body mass and composition in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Changes in height, weight and plasma leptin after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

The role of iron in patients after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

The quality of life of adult survivors of childhood hematopoietic cell transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2014.3

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

21 January 2018

1 reference

12 December 2020

Permanent chemotherapy-induced alopecia: a review

1 reference

12 December 2020

Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: the impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moe

1 reference

12 December 2020

Health status and quality of life in long-term survivors of childhood leukaemia: the impact of haematopoietic stem cell transplantation

1 reference

12 December 2020

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemothe

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2014.3

1 reference

8 February 2018

1 reference

8 February 2018